World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
152
Citations
81758
World Ranking
1083
National Ranking
622

Overview

William R. Jarnagin is affiliated with Memorial Sloan Kettering Cancer Center in the United States. The primary focus of their research lies within the field of Medicine, with significant contributions to Oncology, Surgery, Pulmonary and Respiratory Medicine, Hepatology, and Cancer Research.

Their work spans multiple topics including:

  • Pancreatic and Hepatic Oncology Research
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cancer Genomics and Diagnostics
  • Gallbladder and Bile Duct Disorders
  • Radiomics and Machine Learning in Medical Imaging
  • Colorectal Cancer Treatments and Studies

William R. Jarnagin has authored or co-authored publications in a range of scientific venues. The most frequent publication outlets include:

  • Annals of Surgical Oncology
  • HPB
  • Journal of Clinical Oncology
  • Annals of Surgery
  • Journal of the American College of Surgeons

Among the notable recent papers associated with their research are:

  • "The Medical Segmentation Decathlon," 2022, published in Nature Communications
  • "Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer," 2023, published in Nature
  • "Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients," 2022, published in Cell
  • "Tumour extracellular vesicles and particles induce liver metabolic dysfunction," 2023, published in Nature
  • "Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma," 2021, published in Hepatology

The scientist collaborates frequently with a number of peers in their field, including:

  • T. Peter Kingham
  • Alice C. Wei
  • Jeffrey A. Drebin
  • Kevin C. Soares
  • Mithat Gönen

Best Publications

  • Tumour exosome integrins determine organotropic metastasis

    Ayuko Hoshino;Bruno Costa-Silva;Tang-Long Shen;Goncalo Rodrigues

  • Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver

    Bruno Costa-Silva;Nicole M. Aiello;Allyson J. Ocean;Swarnima Singh

  • Improvement in Perioperative Outcome After Hepatic Resection: Analysis of 1,803 Consecutive Cases Over the Past Decade

    William R. Jarnagin;Mithat Gonen;Yuman Fong;Ronald P. DeMatteo

  • Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.

    William R. Jarnagin;Yuman Fong;Ronald P. DeMatteo;Mithat Gonen

  • Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka

    Go Wakabayashi;Daniel Cherqui;David A. Geller;Joseph E. Buell

  • Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure

    James S. Tomlinson;William R. Jarnagin;Ronald P. DeMatteo;Yuman Fong

  • Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

    Ayuko Hoshino;Ayuko Hoshino;Han Sang Kim;Han Sang Kim;Linda Bojmar;Linda Bojmar;Linda Bojmar;Kofi Ennu Gyan

  • The Medical Segmentation Decathlon

    Michela Antonelli;Annika Reinke;Spyridon Bakas;Keyvan Farahani

  • An analysis of 412 cases of hepatocellular carcinoma at a Western center.

    Yuman Fong;Ruth L. Sun;William Jarnagin;Leslie H. Blumgart

  • Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.

    Itaru Endo;Mithat Gonen;Adam C. Yopp;Kimberly M. Dalal

  • A large annotated medical image dataset for the development and evaluation of segmentation algorithms

    Amber L. Simpson;Michela Antonelli;Spyridon Bakas;Michel Bilello

  • Influence of Transfusions on Perioperative and Long-Term Outcome in Patients Following Hepatic Resection for Colorectal Metastases

    David A. Kooby;Jennifer Stockman;Leah Ben-Porat;Mithat Gonen

  • Hepatic neuroendocrine metastases: does intervention alter outcomes?

    Ronald S Chamberlain;David Canes;Karen T Brown;Leonard Saltz

  • Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas

    Yuchen Jiao;Timothy M Pawlik;Robert A Anders;Florin M Selaru

  • Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system.

    Edmund C. Burke;William R. Jarnagin;Steven N. Hochwald;Peter W. T. Pisters

  • Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction.

    Jose A Melendez;Vittoria Arslan;Mary E Fischer;David Wuest

  • Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution.

    Michael G. House;Hiromichi Ito;Mithat Gönen;Yuman Fong

  • Prospective Randomized Clinical Trial of the Value of Intraperitoneal Drainage After Pancreatic Resection

    Kevin C. Conlon;Daniel Labow;Dennis Leung;Alex Smith

  • Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection.

    Margo Shoup;Mithat Gonen;Michael D'Angelica;William R Jarnagin

  • Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.

    William R. Jarnagin;Leyo Ruo;Sarah A. Little;David Klimstra

Frequent Co-Authors

Michael I. D’Angelica
Michael I. D’Angelica Memorial Sloan Kettering Cancer Center
Ronald P. DeMatteo
Ronald P. DeMatteo University of Pennsylvania
Peter J. Allen
Peter J. Allen Duke University
Yuman Fong
Yuman Fong City Of Hope National Medical Center
Mithat Gonen
Mithat Gonen Memorial Sloan Kettering Cancer Center
T. Peter Kingham
T. Peter Kingham Memorial Sloan Kettering Cancer Center
Leslie H. Blumgart
Leslie H. Blumgart Memorial Sloan Kettering Cancer Center
Nancy E. Kemeny
Nancy E. Kemeny Memorial Sloan Kettering Cancer Center
David S. Klimstra
David S. Klimstra Yale University
Murray F. Brennan
Murray F. Brennan Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always begin with medical school. There are several flexible online degree paths available for those interested in healthcare. For example, aspiring professionals can start with focused programs like medical billing and coding financial aid, which helps students access essential support to enter the healthcare field quickly and affordably.

For students interested in nursing, there are options for nursing school no entrance exam programs—ideal for those looking to bypass standardized test requirements and start their nursing education sooner.

Leadership roles in the medical sector are accessible through healthcare administration programs that are offered online and designed to be completed at an accelerated pace.

Lastly, registered nurses who want to progress can explore adn to fnp programs, bridging the gap to advanced clinical practice and opening new opportunities in patient care and leadership.

Best Scientists Citing William R. Jarnagin

Trending Scientists

Recently Published Articles